Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02927210 · ClinicalTrials.gov registry record · Phase 1
Injectable DMAU for Male Contraception in Healthy Male Volunteers (CCN015)
A Phase 1 study, sponsored by Kimberly Myer.
- Completed
- Registry status
- Phase 1
- Development phase
- 106
- Enrollment target
NCT02927210: Completed Phase 1 study, sponsored by Kimberly Myer.
NCT02927210 is a Phase 1 study that has completed, run by Kimberly Myer. The registered enrollment target is 106 participants, above the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (77% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02927210, a Phase 1 study, has completed, sponsored by Kimberly Myer.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 106 participants
- Enrollment target
Study Summary
This is a Phase I multicenter, double-blind, single dose, dose-ranging study, in healthy men to evaluate the safety and tolerability, pharmacokinetics and pharmacodynamics of Dimethandrolone Undecanoate (DMAU) administered as an intramuscular or subcutaneous injection.
Interventions
- DRUG Placebo
- DRUG Dimethandrolone Undecanoate
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 106 participants |
| Start Date | 2017-02-15 |
| Est. Completion | 2025-04-29 |
| Phase | Phase 1 |
What the finished NCT02927210 record still lists
NCT02927210 is an interventional study that assigns participants to a tested intervention. The registered 106 participants enrollment target is mid-sized for trials with a published cap, above the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (77% higher).
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT02927210 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02927210 about?
NCT02927210 is a clinical study titled "Injectable DMAU for Male Contraception in Healthy Male Volunteers (CCN015)". This is a Phase I multicenter, double-blind, single dose, dose-ranging study, in healthy men to evaluate the safety and tolerability, pharmacokinetics and pharmacodynamics of Dimethandrolone Undecanoate (DMAU) administered as an intramuscular or subcutaneous injection.
What is the current status of trial NCT02927210?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 106 participants. The study started on 2017-02-15. Estimated completion is 2025-04-29.
What interventions are being tested in trial NCT02927210?
The interventions under investigation include: Placebo (DRUG), Dimethandrolone Undecanoate (DRUG).
Who is sponsoring clinical trial NCT02927210?
This trial is sponsored by Kimberly Myer, which has 5 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02927210's enrollment target sits among peer trials
106 531st of 2000 higher than 1,468 of 2,000 other Phase 1 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03181048 · 106 participants · NA
Clinical Trial of Concomitant Hip Arthroscopy During PAO
- NCT04682158 · 106 participants · Phase 2
Propranolol With Standard Chemoradiation for Esophageal Adenocarcinoma
- NCT04724018 · 106 participants · Phase 1
Sacituzumab Govitecan Plus EV in Metastatic UC
- NCT04798274 · 106 participants · NA
Role of GABAergic Transmission in Auditory Processing in Autism Spectrum Disorder
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI